Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph T Lundquist

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Organic Letters|September 14, 2002
A new tri-orthogonal strategy for peptide cyclizationJoseph T Lundquist, Jeffrey C Pelletier
Organic Letters|August 25, 2006
Mild and adaptable silver triflate-assisted method for trityl protection of alcohols in solution with solid-phase loading applicationsJoseph T Lundquist, Andrew D Satterfield, Jeffrey C Pelletier
Organic Letters|February 13, 2009
Efficient, regioselective palladium-catalyzed tandem Heck-isomerization reaction of aryl bromides and non-allylic benzyl alcoholsMatthew L Crawley, Kristin M Phipps, Igor Goljer, et al.
Bioorganic & Medicinal Chemistry Letters|August 18, 2009
Pyrrole[2,3-d]azepino compounds as agonists of the farnesoid X receptor (FXR)John F Mehlmann, Matthew L Crawley, Joseph T Lundquist, et al.
Bioorganic & Medicinal Chemistry|May 31, 2008
2-phenyl-4-piperazinylbenzimidazoles: orally active inhibitors of the gonadotropin releasing hormone (GnRH) receptorJeffrey C Pelletier, Murty Chengalvala, Josh Cottom, et al.
Bioorganic & Medicinal Chemistry Letters|March 19, 2010
Synthesis and biological evaluation of piperazinyl heterocyclic antagonists of the gonadotropin releasing hormone (GnRH) receptorMatthew D Vera, Joseph T Lundquist, Murty V Chengalvala, et al.
Bioorganic & Medicinal Chemistry Letters|March 3, 2009
Small molecule antagonists of the gonadotropin-releasing hormone (GnRH) receptor: structure-activity relationships of small heterocyclic groups appended to the 2-phenyl-4-piperazinyl-benzimidazole templateDiane B Hauze, Murty V Chengalvala, Joshua E Cottom, et al.
Journal of Medicinal Chemistry|January 26, 2010
Improvement of physiochemical properties of the tetrahydroazepinoindole series of farnesoid X receptor (FXR) agonists: beneficial modulation of lipids in primatesJoseph T Lundquist, Douglas C Harnish, Callain Y Kim, et al.
Journal of Medicinal Chemistry|March 11, 2009
Discovery of 6-({4-[2-(4-tert-butylphenyl)-1H-benzimidazol-4-yl]piperazin-1-yl}methyl)quinoxaline (WAY-207024): an orally active antagonist of the gonadotropin releasing hormone receptor (GnRH-R)Jeffrey C Pelletier, Murty V Chengalvala, Joshua E Cottom, et al.
Journal of Medicinal Chemistry|October 28, 2009
(1-(4-(Naphthalen-2-yl)pyrimidin-2-yl)piperidin-4-yl)methanamine: a wingless beta-catenin agonist that increases bone formation rateJeffrey C Pelletier, Joseph T Lundquist, Adam M Gilbert, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Organic Letters|September 14, 2002
A new tri-orthogonal strategy for peptide cyclizationJoseph T Lundquist, Jeffrey C Pelletier
Organic Letters|August 25, 2006
Mild and adaptable silver triflate-assisted method for trityl protection of alcohols in solution with solid-phase loading applicationsJoseph T Lundquist, Andrew D Satterfield, Jeffrey C Pelletier
Organic Letters|February 13, 2009
Efficient, regioselective palladium-catalyzed tandem Heck-isomerization reaction of aryl bromides and non-allylic benzyl alcoholsMatthew L Crawley, Kristin M Phipps, Igor Goljer, et al.
Bioorganic & Medicinal Chemistry Letters|August 18, 2009
Pyrrole[2,3-d]azepino compounds as agonists of the farnesoid X receptor (FXR)John F Mehlmann, Matthew L Crawley, Joseph T Lundquist, et al.
Bioorganic & Medicinal Chemistry|May 31, 2008
2-phenyl-4-piperazinylbenzimidazoles: orally active inhibitors of the gonadotropin releasing hormone (GnRH) receptorJeffrey C Pelletier, Murty Chengalvala, Josh Cottom, et al.
Bioorganic & Medicinal Chemistry Letters|March 19, 2010
Synthesis and biological evaluation of piperazinyl heterocyclic antagonists of the gonadotropin releasing hormone (GnRH) receptorMatthew D Vera, Joseph T Lundquist, Murty V Chengalvala, et al.
Bioorganic & Medicinal Chemistry Letters|March 3, 2009
Small molecule antagonists of the gonadotropin-releasing hormone (GnRH) receptor: structure-activity relationships of small heterocyclic groups appended to the 2-phenyl-4-piperazinyl-benzimidazole templateDiane B Hauze, Murty V Chengalvala, Joshua E Cottom, et al.
Journal of Medicinal Chemistry|January 26, 2010
Improvement of physiochemical properties of the tetrahydroazepinoindole series of farnesoid X receptor (FXR) agonists: beneficial modulation of lipids in primatesJoseph T Lundquist, Douglas C Harnish, Callain Y Kim, et al.
Journal of Medicinal Chemistry|March 11, 2009
Discovery of 6-({4-[2-(4-tert-butylphenyl)-1H-benzimidazol-4-yl]piperazin-1-yl}methyl)quinoxaline (WAY-207024): an orally active antagonist of the gonadotropin releasing hormone receptor (GnRH-R)Jeffrey C Pelletier, Murty V Chengalvala, Joshua E Cottom, et al.
Journal of Medicinal Chemistry|October 28, 2009
(1-(4-(Naphthalen-2-yl)pyrimidin-2-yl)piperidin-4-yl)methanamine: a wingless beta-catenin agonist that increases bone formation rateJeffrey C Pelletier, Joseph T Lundquist, Adam M Gilbert, et al.
Pageof 1